Jason M. Meggs

Jason M. Meggs, listed as finance chief, appears in our data through filings on Syneos Health, Inc. shares, published by SEC (Form 4). In total, 56 filings cover trades dated from 30 July 2018 to 23 February 2023.

The open-market side counts 3 purchases for €256k alongside 10 sales for €2.8M. On balance, insiders were net sellers of €2.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 36 share grants and 5 option exercises.

Half of the purchases are above €121k and half below. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 24 February 2023, reports a share grant in Syneos Health, Inc. The last purchase on record was published on 23 March 2020, which is 2,421 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.